Prm157 - The Impact of Landmark Response on Overall Survival: Implications for the Economic Evaluation of Immune-Therapy (I-O) Treatment in Small Cell Lung Cancer (Sclc)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2277
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV